Cognitive and Emotional Factors in Visual Exploration Among Patients With Post-Traumatic Stress Disorder (SAILLANCE2) (SAILLANCE2)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03519789|
Recruitment Status : Recruiting
First Posted : May 9, 2018
Last Update Posted : February 15, 2019
|Condition or disease|
|Post-Traumatic Stress Disorder|
|Study Type :||Observational|
|Estimated Enrollment :||60 participants|
|Official Title:||Cognitive and Emotional Factors in Visual Exploration Among Patients With Post-Traumatic Stress Disorder|
|Study Start Date :||May 2014|
|Estimated Primary Completion Date :||May 2020|
|Estimated Study Completion Date :||May 2020|
Post-Traumatic Stress Disorders (PTSD)
30 patients with PTSD (diagnosis based on the standard DSM criteria)
30 healthy controls without any psychiatric or neurological diagnosis
- Response time before the detection of neutral and emotional stimuli. [ Time Frame: Baseline: one session ]The explicit response of the participants will be measured with the response time before the detection of neutral and emotional stimuli.
- Number of correct detections compared with the missed detections and false alarms. [ Time Frame: Baseline: one session ]Performances will be measured by a sensitivity index (D prime) . This sensitivity index considers the number of correct detections compared with the missed detections and false alarms.
- Total duration until the participant first fixed on a ROI. [ Time Frame: Baseline: one session ]The implicit response will be measured by the localization and duration of fixations. All fixations outside the recording field will be excluded. The main variable will be the mean latency of the first fixation in a region of interest (ROI). This variable corresponds to the total duration until the participant first fixed on a ROI.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03519789
|Contact: Pierre GRANDGENEVRE||+33 3 20 44 45 email@example.com|
|Contact: Anne-Laure DEMARTY||+33 3 20 44 68 firstname.lastname@example.org|
|University Hospital, Lille||Recruiting|
|Lille, France, 59037|
|Principal Investigator: Guillaume VAIVA|
|Sub-Investigator: Pierre GRANDGENEVRE|
|Principal Investigator:||Guillaume VAIVA||University Hospital, Lille|